Merz Pharma
- Company typePrivate
- Founded1908
- HeadquartersDeutsch, Germany
- Headcount5,001–10,000
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
Merz Pharma firmographics
Firmographics- Name
- Merz Pharma
- Legal name
- Merz Pharma GmbH & Co.KGaA
- Website
- https://merz.com
- Company type
- Private
- Founded year
- 1908
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Ownership category
- akta.pro rank
Merz Pharma industry classification
Industry- Product category
- Aesthetic Medicine and Pharmaceuticals
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)
- akta.pro secondary industry
- Specialty Care Pharmaceuticals (HLAIAAAB)
Keywords
Where Merz Pharma is headquartered
LocationHeadquarters
- HQ city
- Deutsch
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Merz Pharma business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Supply Chain
Distribution channels1 record
Marketing channels3 records
Merz Pharma product offering
Product offeringCore offering
Merz Pharma is a diversified healthcare company that develops, manufactures, and markets aesthetic medicine products (neurotoxins like XEOMIN/Bocouture, dermal fillers like BELOTERO, and the Ultherapy PRIME ultrasound device for non-invasive skin lifting), neurological disorder therapeutics (XEOMIN for spasticity and sialorrhea), and consumer health and wellness products (tetesept, SOS, Zirkulin, Merz Spezial, Brooklyn Soap Company) through three business units: Merz Aesthetics, Merz Therapeutics, and Merz Lifecare.
Product overview
Merz Pharma operates as a diversified healthcare company organized into three main business units: Merz Aesthetics (aesthetic medicine and skin rejuvenation products), Merz Therapeutics (neurological disorder treatments including botulinum toxin-based therapies like XEOMIN and Bocouture), and Merz Lifecare (consumer health brands including tetesept, SOS, Zirkulin, and Brooklyn Soap Company). The company also offers medical devices like Ultherapy PRIME for non-invasive skin lifting and BELOTERO dermal fillers. Founded in 1908 and headquartered in Frankfurt, Germany, Merz is a family-owned company celebrating over 110 years of operation.
Differentiator
Problem solved
Functional benefit
Brands
- Ultherapy PRIME: FDA-cleared ultrasound treatment with real-time visualization for skin lifting
- BELOTERO
- XEOMIN
- Bocouture
- tetesept
- SOS
- Zirkulin
- Merz Spezial
- Brooklyn Soap Company
Products and services
- Merz Aesthetics
- Merz Therapeutics
- Merz Lifecare
- Ultherapy PRIME
- BELOTERO
- XEOMIN (incobotulinumtoxinA)
- Bocouture
Companies that use Merz Pharma
Customer profileSegments3 records
Ideal customer profiles3 records
Merz Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Merz Pharma partnerships and signals
Strategic signalRecent moves6 records
Expansion highlights5 records
Merz Pharma competitors and assessment
Company assessmentDirect peers
- Galderma: Pure-play dermatology company offering Restylane and Sculptra filler franchises plus a prescription skincare portfolio. Directly comparable to Merz Aesthetics in hyaluronic acid fillers and dermatology-focused product strategy, and a key competitor in physician-dispensed aesthetics channels.
- Allergan Aesthetics (AbbVie): AbbVie's aesthetics division markets Botox (onabotulinumtoxinA), the global market-leading neurotoxin, plus the Juvéderm filler portfolio and CoolSculpting body-contouring devices. Direct head-to-head competitor to Merz Aesthetics' XEOMIN/Bocouture, BELOTERO and Ultherapy across both medical aesthetics and select neurology indications.
- Sinclair Pharma: Aesthetic medicine company with hyaluronic acid fillers (MaiLi) and collagen-stimulator (Ellansé) franchises distributed through medical aesthetic practices. Directly comparable to Merz Aesthetics' filler and biostimulator portfolio across Europe and Asia.
- Ipsen: Markets Dysport (abobotulinumtoxinA) for both aesthetic and therapeutic (spasticity) indications. Directly competes with Merz's XEOMIN in neurology specialty care and Bocouture in aesthetics, with overlapping indication development in movement disorders.
Emerging players
- Revance Therapeutics: Aesthetics and therapeutics company with the RHA dermal filler line and the DaxibotulinumtoxinA neuromodulator programme. Overlaps with Merz Aesthetics across fillers and neurotoxins and with Merz Therapeutics in neurology pipeline development.
- Croma-Pharma: Austrian aesthetics company focused on hyaluronic acid fillers (Princess), botulinum toxin and PRP, plus ophthalmology. Overlaps with Merz Aesthetics' filler franchise and competes in similar medical-aesthetic distribution channels across Europe.
- Cynosure / Lutronic: Aesthetic energy-based device manufacturers offering laser, RF and ultrasound platforms. Compete with Merz's Ultherapy PRIME in non-invasive skin lifting/tightening and adjacent aesthetic device capital sales to medical practices.
- Evolus: US-focused aesthetics company marketing Jeuveau (prabotulinumtoxinA), a neurotoxin positioned as a value alternative to Botox. Competes with Bocouture and XEOMIN in the medical aesthetics channel, particularly with price-sensitive practices.
- Hugel: South Korean specialty company with Botulax (botulinum toxin type A) and a dermal filler portfolio. Increasingly competing with Merz's neurotoxin brands in Asia-Pacific and Latin America aesthetics markets.
Broad incumbents
- Bausch Health (Solta Medical): Through Solta Medical, Bausch markets energy-based aesthetic devices (Thermage, Fraxel, Clear+Brilliant) that compete with Merz's Ultherapy platform. Also operates the orthodermatology Salix portfolio, giving partial overlap with Merz Aesthetics' device and skincare positions.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Merz Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Merz Pharma leadership team
Management profileNumber of profiles
Profiles6 records
Merz Pharma subsidiaries and ownership
Company hierarchySubsidiaries5 records
Merz Pharma funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Merz Pharma M&A and investment
M&A and investmentM&A5 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Merz Pharma
What does Merz Pharma do?
Merz Pharma is a diversified healthcare company that develops, manufactures, and markets aesthetic medicine products (neurotoxins like XEOMIN/Bocouture, dermal fillers like BELOTERO, and the Ultherapy PRIME ultrasound device for non-invasive skin lifting), neurological disorder therapeutics (XEOMIN for spasticity and sialorrhea), and consumer health and wellness products (tetesept, SOS, Zirkulin, Merz Spezial, Brooklyn Soap Company) through three business units: Merz Aesthetics, Merz Therapeutics, and Merz Lifecare.
Is Merz Pharma a public or private company?
Merz Pharma is a private company. It is classified as family owned and is currently operating.
When was Merz Pharma founded?
Merz Pharma was founded in 1908. It employs 5,001 to 10,000 people.
Where is Merz Pharma based?
Merz Pharma is headquartered in Deutsch, Germany, in the Europe region.
Who are Merz Pharma's main competitors?
Direct peers on record are Galderma, Allergan Aesthetics (AbbVie), Sinclair Pharma and Ipsen. Emerging players are Revance Therapeutics, Croma-Pharma, Cynosure / Lutronic, Evolus and Hugel. Bausch Health (Solta Medical) is listed as a broad incumbent.
Does Merz Pharma have an API?
No public API is recorded for Merz Pharma.
What industry is Merz Pharma in?
Merz Pharma's product category is Aesthetic Medicine and Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAK, Dermatology & Aesthetics Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325414 and its SIC code is 2834.